About
Antibody Therapies
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibody
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
63
By Phase
PHASE1: 1PHASE1/PHASE2: 1
By Status
TERMINATED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06299163Lead Sponsor
NM32-2668 in Adult Patients With Selected Advanced Solid Tumors
PHASE1Terminated
11 participants
Started: May 1, 2024 · Completed: Apr 18, 2025
NCT04442126Lead Sponsor
A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors
PHASE1/PHASE2Terminated
52 participants
Started: Aug 19, 2020 · Completed: Feb 6, 2024
Locations (1)
Headquarters
Horgen, Switzerland
Map
Loading map...